185 related articles for article (PubMed ID: 29633146)
1. Sequential clomiphene/corifollitrophin alpha as a technique for mild controlled ovarian hyperstimulation in IVF: a proof of concept study.
Zander-Fox D; Lane M; Hamilton H; Tremellen K
J Assist Reprod Genet; 2018 Jun; 35(6):1047-1052. PubMed ID: 29633146
[TBL] [Abstract][Full Text] [Related]
2. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
Branigan EF; Estes MA
Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
[TBL] [Abstract][Full Text] [Related]
3. Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate.
Ochin H; Ma X; Wang L; Li X; Song J; Meng Y; Shen J; Cui YG; Liu J
J Ovarian Res; 2018 May; 11(1):37. PubMed ID: 29728130
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
[TBL] [Abstract][Full Text] [Related]
5. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
6. Recent clomiphene citrate exposure does not impact subsequent clinical outcomes in single euploid frozen embryo transfer cycles.
Hernandez-Nieto C; Lee J; Alkon-Meadows T; Soto-Cossio L; Sandler B; Mukherjee T; Copperman A
Hum Reprod; 2023 Jun; 38(6):1151-1161. PubMed ID: 37075318
[TBL] [Abstract][Full Text] [Related]
7. Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis.
Bechtejew TN; Nadai MN; Nastri CO; Martins WP
Ultrasound Obstet Gynecol; 2017 Sep; 50(3):315-323. PubMed ID: 28236310
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
[TBL] [Abstract][Full Text] [Related]
9. Use of Clomiphene Citrate in minimal stimulation in vitro fertilization negatively impacts endometrial thickness: an argument for a freeze-all approach.
Reed BG; Wu JL; Nemer LB; Carr BR; Bukulmez O
JBRA Assist Reprod; 2018 Nov; 22(4):355-362. PubMed ID: 30264948
[TBL] [Abstract][Full Text] [Related]
10. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY
Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229
[No Abstract] [Full Text] [Related]
11. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
12. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
[TBL] [Abstract][Full Text] [Related]
13. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study.
Weigert M; Krischker U; Pöhl M; Poschalko G; Kindermann C; Feichtinger W
Fertil Steril; 2002 Jul; 78(1):34-9. PubMed ID: 12095487
[TBL] [Abstract][Full Text] [Related]
14. Clomiphene combined with gonadotropins and GnRH antagonist versus conventional controlled ovarian hyperstimulation without clomiphene in women undergoing assisted reproductive techniques: systematic review and meta-analysis.
Figueiredo JB; Nastri CO; Vieira AD; Martins WP
Arch Gynecol Obstet; 2013 Apr; 287(4):779-90. PubMed ID: 23250342
[TBL] [Abstract][Full Text] [Related]
15. Addition of low-dose hCG to rFSH during ovarian stimulation for IVF/ICSI: is it beneficial?
Partsinevelos GA; Antonakopoulos N; Kallianidis K; Drakakis P; Anagnostou E; Bletsa R; Loutradis D
Clin Exp Obstet Gynecol; 2016; 43(6):818-825. PubMed ID: 29944230
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
17. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
18. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
19. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
[TBL] [Abstract][Full Text] [Related]
20. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]